Kwon D, Kim S, Correia M
Acta Pharm Sin B. 2020; 10(1):42-60.
PMID: 31993306
PMC: 6976991.
DOI: 10.1016/j.apsb.2019.11.002.
Czaja A
World J Gastroenterol. 2019; 25(45):6579-6606.
PMID: 31832000
PMC: 6906207.
DOI: 10.3748/wjg.v25.i45.6579.
Qian Y, Yang Y, Wang K, Zhou W, Dang Y, Zhu M
Front Pharmacol. 2019; 10:1390.
PMID: 31824319
PMC: 6880759.
DOI: 10.3389/fphar.2019.01390.
Matsumoto K, Kikuchi K, Kajiyama Y, Takano Y, Mabuchi M, Doi S
Intern Med. 2018; 57(18):2669-2673.
PMID: 29709942
PMC: 6191578.
DOI: 10.2169/internalmedicine.0613-17.
Ramos C, Sa R, Alves M, Benedito R, de Sousa D, Diniz M
Toxicol Rep. 2017; 2:482-488.
PMID: 28962384
PMC: 5598502.
DOI: 10.1016/j.toxrep.2015.01.001.
Changes in IL-2 and IL-10 during Chronic Administration of Isoniazid, Nevirapine, and Paracetamol in Rats.
Bekker Z, Walubo A, Du Plessis J
Adv Pharmacol Sci. 2016; 2016:3094783.
PMID: 27990159
PMC: 5136381.
DOI: 10.1155/2016/3094783.
Drug Induced Autoimmune Hepatitis by Amoxicillin-Clavulanate.
Kuzu U, Oztas E, Kaplan M, Suna N, Keklik T, Akdogan M
Iran J Public Health. 2016; 45(4):540-1.
PMID: 27252926
PMC: 4888184.
An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
Hisamochi A, Kage M, Ide T, Arinaga-Hino T, Amano K, Kuwahara R
J Gastroenterol. 2015; 51(6):597-607.
PMID: 26519284
DOI: 10.1007/s00535-015-1131-7.
Oral clindamycin causing acute cholestatic hepatitis without ductopenia: a brief review of idiosyncratic drug-induced liver injury and a case report.
Moole H, Ahmed Z, Saxena N, Puli S, Dhillon S
J Community Hosp Intern Med Perspect. 2015; 5(5):28746.
PMID: 26486111
PMC: 4612703.
DOI: 10.3402/jchimp.v5.28746.
Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.
Czaja A
Dig Dis Sci. 2015; 60(10):2881-900.
PMID: 25999246
DOI: 10.1007/s10620-015-3708-7.
Acute hepatitis after starting pinaverium bromide in a patient taking mirtazapine.
Tak S, Tak S
BMJ Case Rep. 2014; 2014.
PMID: 25015163
PMC: 4112329.
DOI: 10.1136/bcr-2013-200947.
DILI: New Insights into Diagnosis and Management.
Tran T, Lee W
Curr Hepat Rep. 2013; 12(1):53-58.
PMID: 23730228
PMC: 3666953.
DOI: 10.1007/s11901-012-0159-x.
Mechanisms of drug-induced liver injury: from bedside to bench.
Tujios S, Fontana R
Nat Rev Gastroenterol Hepatol. 2011; 8(4):202-11.
PMID: 21386809
DOI: 10.1038/nrgastro.2011.22.
Drug-induced autoimmune-like hepatitis.
Czaja A
Dig Dis Sci. 2011; 56(4):958-76.
PMID: 21327704
DOI: 10.1007/s10620-011-1611-4.
Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.
Shaw P, Ganey P, Roth R
Toxicol Sci. 2010; 118(1):7-18.
PMID: 20538741
PMC: 2955207.
DOI: 10.1093/toxsci/kfq168.
Severe prolonged cholestatic hepatitis caused by exemestane.
Bao T, Fetting J, Mumford L, Zorzi J, Shahverdi K, Jeter S
Breast Cancer Res Treat. 2009; 121(3):789-91.
PMID: 19834799
PMC: 3085997.
DOI: 10.1007/s10549-009-0576-x.
Current concepts of mechanisms in drug-induced hepatotoxicity.
Russmann S, Kullak-Ublick G, Grattagliano I
Curr Med Chem. 2009; 16(23):3041-53.
PMID: 19689281
PMC: 2765083.
DOI: 10.2174/092986709788803097.
Drug-induced liver injury.
Abboud G, Kaplowitz N
Drug Saf. 2007; 30(4):277-94.
PMID: 17408305
DOI: 10.2165/00002018-200730040-00001.
Drug-metabolizing cytochrome P450s in the brain.
Miksys S, Tyndale R
J Psychiatry Neurosci. 2002; 27(6):406-15.
PMID: 12491573
PMC: 161713.
Drug-induced liver disorders: implications for drug development and regulation.
Kaplowitz N
Drug Saf. 2001; 24(7):483-90.
PMID: 11444721
DOI: 10.2165/00002018-200124070-00001.
